SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-000023
Filing Date
2024-01-02
Accepted
2024-01-02 08:49:12
Documents
13
Period of Report
2024-01-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20017827_8k.htm   iXBRL 8-K 28224
2 EXHIBIT 10.1 ef20017827_ex10.htm EX-10.1 18204
  Complete submission text file 0001140361-24-000023.txt   185408

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA siga-20240101.xsd EX-101.SCH 3854
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE siga-20240101_lab.xml EX-101.LAB 22547
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE siga-20240101_pre.xml EX-101.PRE 16037
7 EXTRACTED XBRL INSTANCE DOCUMENT ef20017827_8k_htm.xml XML 4052
Mailing Address 31 EAST 62ND STREET NEW YORK NY 10065
Business Address 31 EAST 62ND STREET NEW YORK NY 10065 212-672-9100
SIGA TECHNOLOGIES INC (Filer) CIK: 0001010086 (see all company filings)

IRS No.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38436 | Film No.: 24500442
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)